Pharmabiz

Healthium Medtech inks MoU with APEDB to expand manufacturing operations in Sri City

Healthium Medtech inks MoU with APEDB to expand manufacturing operations in Sri City: Our Bureau, Benglauru Thursday, November 20, 2025, 14:50 Hrs [IST] Healthium Medtech, a globa ...
Pharmabiz

NIHR to support the Men’s Health Strategy through research

The NIHR has reaffirmed its commitment to men's health by laying out key research priorities and planned investments as part of the government’s national Men’s Health Strategy. The strategy outlines ...
Pharmabiz

C-CAMP–anchored India AMR Innovation Hub now innovation arm of India’s National Action Plan on AMR

C-CAMP–anchored India AMR Innovation Hub now innovation arm of India’s National Action Plan on AMR: Our Bureau, Bengaluru Thursday, November 20, 2025, 14:30 Hrs [IST] Centre f ...
Pharmabiz

Qure.ai partners with Microsoft to increase access to its lung cancer detection and management suite in the US

Qure.ai partners with Microsoft to increase access to its lung cancer detection and management suite in the US: Our Bureau, Bengaluru Thursday, November 20, 2025, 13:40 Hrs [IST] ...
Pharmabiz

Merck announces EC approves SC administration of Keytruda for all adult indications approved in the European Union

Rahway, New Jersey Thursday, November 20, 2025, 14:00 Hrs [IST] ...
Pharmabiz

Viking Therapeutics completes enrollment in phase 3 VANQUISH-1 trial of VK2735 to treat metabolic disorders

Viking Therapeutics completes enrollment in phase 3 VANQUISH-1 trial of VK2735 to treat metabolic disorders: San Diego Thursday, November 20, 2025, 13:00 Hrs [IST] Viking Therapeu ...
Pharmabiz

SeQuent Scientific and Viyash Lifesciences receive NCLT approval for merger

SeQuent Scientific and Viyash Lifesciences receive NCLT approval for merger: Our Bureau, Mumbai Thursday, November 20, 2025, 14:40 Hrs [IST] SeQuent Scientific Ltd, a leading play ...
Pharmabiz

Mpower releases 5-year data highlighting mental health challenges

Mpower releases 5-year data highlighting mental health challenges: Our Bureau, Bengaluru Thursday, November 20, 2025, 14:15 Hrs [IST] Mpower, an initiative of the Aditya Birla Edu ...
Pharmabiz

European Commission grants conditional marketing approval for Roche’s Lunsumio subcutaneous for R/R follicular lymphoma

European Commission grants conditional marketing approval for Roche’s Lunsumio subcutaneous for R/R follicular lymphoma: Basel Thursday, November 20, 2025, 12:00 Hrs [IST] Roche ...
Pharmabiz

Sound precision in prostate cancer: Focused ultrasound (HIFU) offers safe, effective treatment: Study

Focused ultrasound (HIFU) offers safe, effective treatment: Study: Krems, Austria Thursday, November 20, 2025, 11:00 Hrs [IST] A multicenter cl ...
Pharmabiz

Bayer’s Lynkuet receives EU marketing approval to treat moderate to severe VMS associated with menopause or endocrine therapy for breast cancer

Bayer’s Lynkuet receives EU marketing approval to treat moderate to severe VMS associated with menopause or endocrine therapy for breast cancer: Berlin Thursday, November 20, 20 ...
Pharmabiz

GSK & LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology

GSK & LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology: London, UK Thursday, November 20, 2025, 09:00 Hrs [IST] GSK plc and LTZ Therapeutics ...